233
Participants
Start Date
December 31, 2013
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2027
Microfracture
Surgical procedure which creates a marrow clot in the prepare cartilage defect.
NOVOCART 3D
combination product- biologic (autologous chondrocytes) /device (scaffold) implant
Mount Sinai Faculty Practice Associates, New York
Plancher Orthopaedics & Sports Medicine, New York
Long Island Bone and Joint Llp, Port Jefferson
Allegheny - Singer Research Institute, Pittsburgh
Penn State Hershey Medical Center, Hershey
St. Luke'S University Health Network, Bethlehem
Temple University Hospital, Philadelphia
University of Virginia, Charlottesville
Advanced Orthopaedics, Richmond
The Orthopaedic Center of Central Virginia Inc, Lynchburg
Paley Orthopedic and Spine Institute, West Palm Beach
Tenet Florida Physician Services, Boca Raton
Clinical Research Solutions, Jackson
University of Kentucky, Lexington
Ohio State University Sports Medicine, Columbus
University of Michigan, Ann Arbor
Tria Orthopaedic Center, Bloomington
Mayo Clinic, Rochester
Northshore University Health System, Evanston
Rush University Medical Center, Chicago
University of Missouri Healthcare, Columbia
Ochsner Health System, New Orleans
Tulsa Bone and Joint Associates, Tulsa
Cu Sports Medicine, Denver
Yampa Valley Medical Center, Steamboat Springs
Saint Alphonsus Medical Group, Meridian
Alpine Orthopaedics, North Logan
UCLA, Los Angeles
Grossmont Orthopaedic Medical Group, La Mesa
Stanford Medicine, Redwood City
University of Alberta, Edmonton
Simon Fraser Orthopaedic Fund, Surrey
Dalhousie University, Halifax
St. Josephs Healthcare Hamilton, Hamilton
Lawson Health Research Institute, London
Lead Sponsor
Aesculap Biologics, LLC
INDUSTRY